Clinical Trial Update: A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation Phase 1/2 study evaluating the tolerability, safety, pharmacokinetics, and preliminary efficacy of chronic topical INO-8875 in adults with ocu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• INO-8875

Snippet

Sponsor: Inotek Pharmaceuticals Corporation | Conditions: Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED